about
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in CambodiaA large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests.Global survey of malaria rapid diagnostic test (RDT) sales, procurement and lot verification practices: assessing the use of the WHO-FIND Malaria RDT Evaluation Programme (2011-2014).Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination.Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.Harmonization of malaria rapid diagnostic tests: best practices in labelling including instructions for use.Pan-Plasmodium band sensitivity for Plasmodium falciparum detection in combination malaria rapid diagnostic tests and implications for clinical managementLarge-scale malaria survey in Cambodia: novel insights on species distribution and risk factors.Deletion of Plasmodium falciparum Histidine-Rich Protein 2 (pfhrp2) and Histidine-Rich Protein 3 (pfhrp3) Genes in Colombian ParasitesTowards high-throughput molecular detection of Plasmodium: new approaches and molecular markersInter-rater reliability of malaria parasite counts and comparison of methods.Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria.Characterization of specimens for quality control of malaria rapid diagnostic tests: what is the best indicator for performance?The inverted cup device for blood transfer on malaria RDTs: ease of use, acceptability and safety in routine use by health workers in Nigeria.
P50
Q21034146-9C8F4B00-7A5A-4A60-A6B7-14E35E9BB409Q33527400-2527EBDF-807F-4420-99BB-1CAFAC4D399BQ33691789-16CC70A8-E54F-4353-8B45-7D480EF63478Q33846640-68205D9A-7540-4740-A743-11A543D730CFQ34560158-CC00078C-ACC2-426D-BADC-817CF3496DA6Q34996285-85B6CBD7-9D46-4AC8-B9F2-6BCDEC0E3315Q35212376-AD8B0933-2348-412C-8F7E-181E735AF975Q35741357-86D8C0B3-94BA-4418-9C8E-056F0FF70EA2Q35828231-AAA69572-33D0-4AD9-B79E-39C38BD4925CQ37203050-786D3123-AD74-4257-AA0D-7CF0B977CEFEQ37460737-0AE6D8CB-08BB-4D4A-A033-F4725A47A66FQ44242195-C94B602B-DF75-4311-B32C-AFEBCD87D9B9Q46790308-EBBC2C18-A71A-4A00-8186-137575805522Q48022096-63FD8F73-7F01-416B-96DF-E499B84AF9FF
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sandra Incardona
@ast
Sandra Incardona
@en
Sandra Incardona
@es
Sandra Incardona
@nl
Sandra Incardona
@sl
type
label
Sandra Incardona
@ast
Sandra Incardona
@en
Sandra Incardona
@es
Sandra Incardona
@nl
Sandra Incardona
@sl
prefLabel
Sandra Incardona
@ast
Sandra Incardona
@en
Sandra Incardona
@es
Sandra Incardona
@nl
Sandra Incardona
@sl
P106
P21
P31
P496
0000-0003-4994-1736